Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment ...

Now the big question is whether the drug's short window of efficacy will make it a commercially-viable product in the marketplace ... for postpartum depression (PPD), but sales of that are small ...